A panel of medical experts discuss the significance of collaborative care and key considerations in the treatment of myelodysplastic syndrome (MDS).
EP. 1: Myelodysplastic Syndrome (MDS) Overview
Ryan Haumschild, PharmD, MS, MBA, CPEL, opens the discussion by defining the MDS disease state.
EP. 2: Distinguishing Between Different MDS Subtypes
An expert perspective on the variety of MDS subtypes is provided.
EP. 3: MDS-Related Complications Impacting Patient Quality of Life
Key opinion leaders discuss how patient quality of life is impacted by MDS treatment-associated challenges.
EP. 4: Economic Implications of MDS Management
Financial considerations in MDS treatment are discussed.
2 Clarke Drive Cranbury, NJ 08512